KATHRYN FISHER: Open Payments
NPI 1568803468 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 4 payments from 3 companies in 2025. Trend: 2023 $126 · 2024 $198 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $125 |
| Gilead Sciences, Inc. | 2 | $42 |
| Melinta Therapeutics, LLC | 1 | $34 |
Products named: Wegovy, Rezzayo.
Industry payments across CA — which companies pay providers there.
